BSE filing, NSE: CHCL. Summary written from the filing by ALFA Finder's alert engine.
Cian Healthcare Ltd: key numbers
- Share price
- ₹34.83
- Market cap
- ₹87.08 Cr
- Revenue (annual)
- ₹28.30 Cr
- Net profit (annual)
- ₹-23.29 Cr
- Promoter holding
- 95.00%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cian Healthcare Ltd
All →Cian Healthcare Merger & Restructuring
Cian Healthcare disposed of its Dr. Smiths Biotech subsidiary under an NCLT-approved resolution plan. Its equity was cancelled with nil consideration receivable.
Cian Healthcare Insolvency Petition
Cian Healthcare's subsidiary Dr. Smiths Biotech ceased to be a subsidiary after NCLT approved Ananta Medicare's resolution plan. Equity was extinguished with no consideration received.
Cian Healthcare Other Announcement
Cian Healthcare filed its quarterly shareholding pattern. The company disclosed it is working to restore public shareholding levels following an NCLT-approved resolution plan.
Cian Healthcare Management Change
Cian Healthcare Limited has appointed M/s. Rasool Singhal & Co. as the new Statutory Auditor for a term of 60 months.
Cian Healthcare Annual General Meeting
Cian Healthcare Ltd held its 23rd AGM on September 29, 2026, approving financial statements, director re-appointment, auditor appointment, and the 2026 Employee Stock Option Scheme.
Cian Healthcare Annual Report
Cian Healthcare Limited has filed its Annual Report for the financial year ended March 31, 2026, and the Notice of its 23rd Annual General Meeting.
Other employee stock options announcements
All →Wipro Employee Stock Options
Wipro allotted 95,503 equity shares under employee RSU and ESOP schemes. The allotment reflects routine employee share issuance with no stated consideration.
Tamilnad Mercantile Bank Employee Stock Options
Tamilnad Mercantile Bank allotted 2,364 equity shares to employees exercising options under its ESOP 2024. Paid-up capital rises to 15,83,53,818 shares.
Vedanta Iron and Steel Employee Stock Options
Vedanta Iron And Steel disclosed the vesting of 2023 ESOS grants on 4 November 2026, covering 55,16,340 options across the demerged group. No exercise price or money realised is determined yet.
- Execution
- 8 months from vesting, or such other period as approved by the NRC
Affle 3I Employee Stock Options
Affle 3i disclosed PIT trades on 2-4 November 2026 covering ESOP-related transfers and designated-person purchases. Rows total about Rs.0.42 Crore in value.
Lodha Developers Employee Stock Options
Lodha Developers allotted 56,654 equity shares under its ESOP 2021-II scheme on November 4, 2026. No price or consideration amount is disclosed.
Marksans Pharma Employee Stock Options
Marksans Pharma allotted 56,250 equity shares to employee stock option grantees under its 2024 scheme. Shares were issued on exercise of vested options.